A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)
Clinical trial NCT00152191 · COMPLETED
Trial details
- NCT number
- NCT00152191
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1996-10-01
- Primary completion
- 2007-10-01
- Enrollment
- 1300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.